(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid

C20H20N4O6 — CID 146599624

IUPAC(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C#C[C@@H]3CN(C(=O)O)CCO3)c21
InChIInChI=1S/C20H20N4O6/c1-22-17-12(5-6-13-11-23(20(28)29)9-10-30-13)3-2-4-14(17)24(19(22)27)15-7-8-16(25)21-18(15)26/h2-4,13,15H,7-11H2,1H3,(H,28,29)(H,21,25,26)/t13-,15?/m1/s1
InChIKeyCFBZRLYHKOGOIK-AFYYWNPRSA-N
MW412.40 g/mol
LogP0.05
Rot. Bonds1

About (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid

(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid (PubChem CID 146599624) has the molecular formula C20H20N4O6 and a molecular weight of 412.40 g/mol. Its IUPAC name is (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid.

Molecular Properties

Compound Name(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid
PubChem CID146599624
Molecular FormulaC20H20N4O6
Molecular Weight412.40 g/mol
Exact Mass412.14
IUPAC Name(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C#C[C@@H]3CN(C(=O)O)CCO3)c21
InChIInChI=1S/C20H20N4O6/c1-22-17-12(5-6-13-11-23(20(28)29)9-10-30-13)3-2-4-14(17)24(19(22)27)15-7-8-16(25)21-18(15)26/h2-4,13,15H,7-11H2,1H3,(H,28,29)(H,21,25,26)/t13-,15?/m1/s1
InChIKeyCFBZRLYHKOGOIK-AFYYWNPRSA-N
XLogP0.05
TPSA122.87 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds1
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500412.40
LogP ≤ 50.05
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid?
The IUPAC name of (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid (CID 146599624) is (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid.
What is the SMILES notation for (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid?
The canonical SMILES for (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid is Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C#C[C@@H]3CN(C(=O)O)CCO3)c21.
What is the InChIKey of (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid?
The InChIKey is CFBZRLYHKOGOIK-AFYYWNPRSA-N. The full InChI is InChI=1S/C20H20N4O6/c1-22-17-12(5-6-13-11-23(20(28)29)9-10-30-13)3-2-4-14(17)24(19(22)27)15-7-8-16(25)21-18(15)26/h2-4,13,15H,7-11H2,1H3,(H,28,29)(H,21,25,26)/t13-,15?/m1/s1.
What are the key properties of (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid?
(2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid has a molecular weight of 412.40 g/mol, XLogP of 0.05, 1 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethynyl]morpholine-4-carboxylic acid is sourced from PubChem (CID 146599624), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).